Quarterly report · Q2
5957.TEDINET S100OXP3
Period2022-01-01 → 2022-06-30
Filed2022-08-10
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥20.9bn | 2022-01-01 → 2022-06-30 | Cons. | Net sales |
| Revenue | ¥40.5bn | 2021-01-01 → 2021-12-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥20.3bn | 2021-01-01 → 2021-06-30 | Cons. | Net sales |
| Operating income | ¥1.2bn | 2022-01-01 → 2022-06-30 | Cons. | Operating income |
| Operating income | ¥1.9bn | 2021-01-01 → 2021-06-30 | Cons. | Operating income |
| Ordinary income | ¥1.5bn | 2022-01-01 → 2022-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥3.5bn | 2021-01-01 → 2021-12-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥2.0bn | 2021-01-01 → 2021-06-30 | Cons. | Ordinary income |
| Profit before tax | ¥1.4bn | 2022-01-01 → 2022-06-30 | Cons. | Income before income taxes |
| Profit before tax | ¥2.1bn | 2021-01-01 → 2021-06-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥833m | 2022-01-01 → 2022-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥2.2bn | 2021-01-01 → 2021-12-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.2bn | 2021-01-01 → 2021-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥980m | 2022-01-01 → 2022-06-30 | Cons. | Profit loss |
| Net income | ¥1.5bn | 2021-01-01 → 2021-06-30 | Cons. | Profit loss |
| Total assets | ¥52.9bn | at 2022-06-30 | Cons. | Assets |
| Total assets | ¥50.9bn | at 2021-12-31 | Cons. | Assets |
| Total assets | ¥49.9bn | at 2021-06-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥18.8bn | at 2022-06-30 | Cons. | Liabilities |
| Total liabilities | ¥18.2bn | at 2021-12-31 | Cons. | Liabilities |
| Net assets / equity | ¥34.1bn | at 2022-06-30 | Cons. | Net assets |
| Net assets / equity | ¥32.7bn | at 2021-12-31 | Cons. | Net assets |
| Net assets / equity | ¥31.5bn | at 2021-06-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥9.6bn | at 2022-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥11.4bn | at 2021-12-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥8.8bn | at 2022-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥10.4bn | at 2021-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥9.8bn | at 2021-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥8.3bn | at 2020-12-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥300m | 2022-01-01 → 2022-06-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥3.7bn | 2021-01-01 → 2021-12-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.9bn | 2021-01-01 → 2021-06-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥1.5bn | 2022-01-01 → 2022-06-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥993m | 2021-01-01 → 2021-12-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥338m | 2021-01-01 → 2021-06-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥661m | 2022-01-01 → 2022-06-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥705m | 2021-01-01 → 2021-12-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥165m | 2021-01-01 → 2021-06-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥22.56 | 2022-01-01 → 2022-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥10.9 | 2022-04-01 → 2022-06-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥59.63 | 2021-01-01 → 2021-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥33.41 | 2021-01-01 → 2021-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥21.2 | 2021-04-01 → 2021-06-30d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 57.4% | at 2022-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 57.4% | at 2021-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 56.6% | at 2021-06-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 30
| Segment | Item | Period | Value |
|---|---|---|---|
| jpcrp040300-q2r_E02296-000Control Systemreportable segment | revenue | 2022-01-01 → 2022-06-30 | ¥2.6bn |
| jpcrp040300-q2r_E02296-000Control Systemreportable segment | revenue external | 2022-01-01 → 2022-06-30 | ¥2.6bn |
| jpcrp040300-q2r_E02296-000Control Systemreportable segment | segment profit | 2022-01-01 → 2022-06-30 | ¥74m |
| jpcrp040300-q2r_E02296-000Fastenerreportable segment | revenue | 2022-01-01 → 2022-06-30 | ¥15.2bn |
| jpcrp040300-q2r_E02296-000Fastenerreportable segment | revenue external | 2022-01-01 → 2022-06-30 | ¥15.2bn |
| jpcrp040300-q2r_E02296-000Fastenerreportable segment | segment profit | 2022-01-01 → 2022-06-30 | ¥624m |
| jpcrp040300-q2r_E02296-000Machineryreportable segment | revenue | 2022-01-01 → 2022-06-30 | ¥3.1bn |
| jpcrp040300-q2r_E02296-000Machineryreportable segment | revenue external | 2022-01-01 → 2022-06-30 | ¥3.1bn |
| jpcrp040300-q2r_E02296-000Machineryreportable segment | segment profit | 2022-01-01 → 2022-06-30 | ¥571m |
| jpcrp040300-q2r_E02296-000Medicalreportable segment | revenue | 2022-01-01 → 2022-06-30 | ¥5m |
| jpcrp040300-q2r_E02296-000Medicalreportable segment | revenue external | 2022-01-01 → 2022-06-30 | ¥5m |
| jpcrp040300-q2r_E02296-000Medicalreportable segment | segment profit | 2022-01-01 → 2022-06-30 | −¥48m |
| —segment total | revenue | 2022-01-01 → 2022-06-30 | ¥20.9bn |
| —segment total | revenue external | 2022-01-01 → 2022-06-30 | ¥20.9bn |
| —segment total | segment profit | 2022-01-01 → 2022-06-30 | ¥1.2bn |
| jpcrp040300-q2r_E02296-000Control Systemreportable segment | revenue | 2021-01-01 → 2021-06-30 | ¥2.6bn |
| jpcrp040300-q2r_E02296-000Control Systemreportable segment | revenue external | 2021-01-01 → 2021-06-30 | ¥2.6bn |
| jpcrp040300-q2r_E02296-000Control Systemreportable segment | segment profit | 2021-01-01 → 2021-06-30 | ¥48m |
| jpcrp040300-q2r_E02296-000Fastenerreportable segment | revenue | 2021-01-01 → 2021-06-30 | ¥14.0bn |
| jpcrp040300-q2r_E02296-000Fastenerreportable segment | revenue external | 2021-01-01 → 2021-06-30 | ¥14.0bn |
| jpcrp040300-q2r_E02296-000Fastenerreportable segment | segment profit | 2021-01-01 → 2021-06-30 | ¥895m |
| jpcrp040300-q2r_E02296-000Machineryreportable segment | revenue | 2021-01-01 → 2021-06-30 | ¥3.7bn |
| jpcrp040300-q2r_E02296-000Machineryreportable segment | revenue external | 2021-01-01 → 2021-06-30 | ¥3.7bn |
| jpcrp040300-q2r_E02296-000Machineryreportable segment | segment profit | 2021-01-01 → 2021-06-30 | ¥944m |
| jpcrp040300-q2r_E02296-000Medicalreportable segment | revenue | 2021-01-01 → 2021-06-30 | ¥24m |
| jpcrp040300-q2r_E02296-000Medicalreportable segment | revenue external | 2021-01-01 → 2021-06-30 | ¥24m |
| jpcrp040300-q2r_E02296-000Medicalreportable segment | segment profit | 2021-01-01 → 2021-06-30 | −¥5m |
| —segment total | revenue | 2021-01-01 → 2021-06-30 | ¥20.3bn |
| —segment total | revenue external | 2021-01-01 → 2021-06-30 | ¥20.3bn |
| —segment total | segment profit | 2021-01-01 → 2021-06-30 | ¥1.9bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 568
| Item | Context | Value | Unit |
|---|---|---|---|
| Provision for directors retirement benefits sga | CurrentYTDDuration | 6235000 | JPY |
| Provision for share based remuneration for directors and other officers sga | Prior1YTDDuration | 7325000 | JPY |
| Provision for share based remuneration for directors and other officers sga | CurrentYTDDuration | 8275000 | JPY |
| Depreciation sga | Prior1YTDDuration | 123172000 | JPY |
| Depreciation sga | CurrentYTDDuration | 130265000 | JPY |
| Development and research expenses sga | Prior1YTDDuration | 229366000 | JPY |
| Development and research expenses sga | CurrentYTDDuration | 219585000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E02296-000FastenerReportableSegmentsMember | 13985695000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E02296-000MachineryReportableSegmentsMember | 3690509000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E02296-000ControlSystemReportableSegmentsMember | 2552616000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E02296-000MedicalReportableSegmentsMember | 23711000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReportableSegmentsMember | 20252533000 | JPY |
| Revenues from external customers | Prior1YTDDuration | 20252533000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E02296-000FastenerReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E02296-000MachineryReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E02296-000ControlSystemReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E02296-000MedicalReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_ReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration | － | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E02296-000FastenerReportableSegmentsMember | 13985695000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E02296-000MachineryReportableSegmentsMember | 3690509000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E02296-000ControlSystemReportableSegmentsMember | 2552616000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E02296-000MedicalReportableSegmentsMember | 23711000 | JPY |
| Net sales | Prior1YTDDuration_ReportableSegmentsMember | 20252533000 | JPY |
| Net sales | Prior1YTDDuration | 20252533000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E02296-000FastenerReportableSegmentsMember | 894519000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E02296-000MachineryReportableSegmentsMember | 944030000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E02296-000ControlSystemReportableSegmentsMember | 47983000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E02296-000MedicalReportableSegmentsMember | -4712000 | JPY |
| Operating income | Prior1YTDDuration_ReportableSegmentsMember | 1881822000 | JPY |
| Operating income | Prior1YTDDuration | 1881822000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E02296-000FastenerReportableSegmentsMember | 15226475000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E02296-000MachineryReportableSegmentsMember | 3070614000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E02296-000ControlSystemReportableSegmentsMember | 2588715000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E02296-000MedicalReportableSegmentsMember | 4612000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReportableSegmentsMember | 20890418000 | JPY |
| Revenues from external customers | CurrentYTDDuration | 20890418000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q2r_E02296-000FastenerReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q2r_E02296-000MachineryReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q2r_E02296-000ControlSystemReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q2r_E02296-000MedicalReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_ReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration | － | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q2r_E02296-000FastenerReportableSegmentsMember | 15226475000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q2r_E02296-000MachineryReportableSegmentsMember | 3070614000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q2r_E02296-000ControlSystemReportableSegmentsMember | 2588715000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q2r_E02296-000MedicalReportableSegmentsMember | 4612000 | JPY |
| Net sales | CurrentYTDDuration_ReportableSegmentsMember | 20890418000 | JPY |
| Net sales | CurrentYTDDuration | 20890418000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q2r_E02296-000FastenerReportableSegmentsMember | 624294000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |